Geode Capital Management, LLC Viking Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,923,305 shares of VKTX stock, worth $76.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,923,305
Previous 1,984,389
3.08%
Holding current value
$76.7 Million
Previous $47.9 Million
6.35%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding VKTX
# of Institutions
452Shares Held
68.3MCall Options Held
7.72MPut Options Held
3.31M-
Vanguard Group Inc Valley Forge, PA10.2MShares$405 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$240 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$150 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.25MShares$129 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$125 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.06B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...